Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Profit After Tax (2022 - 2025)

Praxis Precision Medicines has reported Profit After Tax over the past 4 years, most recently at -$88.9 million for Q4 2025.

  • Quarterly results put Profit After Tax at -$88.9 million for Q4 2025, down 51.52% from a year ago — trailing twelve months through Dec 2025 was -$303.3 million (down 65.88% YoY), and the annual figure for FY2025 was -$303.3 million, down 65.88%.
  • Profit After Tax for Q4 2025 was -$88.9 million at Praxis Precision Medicines, down from -$73.9 million in the prior quarter.
  • Over the last five years, Profit After Tax for PRAX hit a ceiling of -$24.6 million in Q3 2023 and a floor of -$88.9 million in Q4 2025.
  • Median Profit After Tax over the past 4 years was -$47.9 million (2022), compared with a mean of -$51.5 million.
  • Biggest five-year swings in Profit After Tax: surged 45.49% in 2023 and later crashed 118.32% in 2024.
  • Praxis Precision Medicines' Profit After Tax stood at -$41.2 million in 2022, then surged by 34.72% to -$26.9 million in 2023, then crashed by 118.32% to -$58.7 million in 2024, then crashed by 51.52% to -$88.9 million in 2025.
  • The last three reported values for Profit After Tax were -$88.9 million (Q4 2025), -$73.9 million (Q3 2025), and -$71.1 million (Q2 2025) per Business Quant data.